Background: To investigate through a two-stage clinic-based screening, the frequency and clinical features of risk for psychosis syndromes in a Chinese help-seeking sample. Method: 2101 consecutive new patients ages 15-45 were recruited at their first visit to the Shanghai Mental Health Center (SMHC) and screened with the Prodromal Questionnaire-Brief version (PQ-B) and questions about genetic risk. The Structured Interview for Prodromal Syndromes (SIPS) was administered to a subsample to estimate rates of psychosis and clinical high risk (CHR) for psychosis syndromes. Results: The frequency estimate of CHR syndromes in the total sample was 4.2%. Among 89 CHR patients, more than two-thirds met the criteria for Attenuated Positive Symptom Syndrome (APSS); and nearly a quarter met the criteria for Genetic Risk and Deterioration Syndrome (GRDS). The frequency of CHR syndromes peaked between the ages of 16 and 21 years old and declined with subsequent age. The mean total and distress scores on the PQ-B in subjects with APSS and psychosis were significantly higher than in individuals with GDRS and patients without psychosis or CHR. High frequencies and strong correlations were found among some positive and non-specific symptoms in SIPS interviews. Among the 53 CHR participants who were followed-up for two years, 14 (26.4%) converted to psychosis. Of the non-converters, 53.8% were diagnosed with Axis I disorders. Conclusions: This two stage screening method can enhance detection of Chinese CHR patients in clinical settings. The validity of the procedures for detecting CHR is supported by rates of transition to psychosis and of nonconverter Axis I disorders that are comparable to those reported in meta-analyses.
Introduction
In order to predict the occurrence of schizophrenia and other related psychotic disorders, many studies in the past two decades have explored potential clinical features (Yung et al., 1998; Klosterkotter et al., 2001; Yung et al., 2005; Schultze-Lutter et al., 2010) , and laboratory markers (Borgwardt et al., 2007; Bramon et al., 2008; Brockhaus-Dumke et al., 2008; Seidman et al., 2010; van Rijn et al., 2011; Fusar-Poli et al., 2012; Giuliano et al., 2012) of the period just preceding or associated with the onset of psychosis. Biomarkers to date, whether considered individually or in combination, are insufficient predictors of psychosis (Klosterkotter et al., 2011) . However, clinical criteria and instruments have been designed to identify young people likely to be in the prodromal psychosis stage, also known as ultra-high risk (UHR), clinical high risk (CHR) or in an at risk mental state (ARMS). Positive symptoms in the prodromal stage often manifest as an attenuated or transient form in which some reality testing is preserved. Nevertheless, they provide a reliable indicator of increased risk for later conversion to psychosis. Researchers in Melbourne, Australia, were the first to translate the clinical symptoms of the prodromal phase of psychosis into UHR criteria (Yung et al., 1996) . In early studies up to 50% of subjects meeting these criteria developed psychosis within 2.5 years (Mason et al., 2004; Yung et al., 2004 Yung et al., , 2006 Yung et al., , 2008 Woods et al., 2009) although recent rates are more modest (Fusar-Poli et al., 2013a,b) , closer to 35% over three years. Subsequently, Miller et al. (1999 Miller et al. ( , 2002 in the United States developed a structured interview based on very similar criteria for predicting the development of psychosis. Thus, trained clinicians are able to identify the help-seeking individuals who are at high risk of developing a psychotic disorder based on attenuated (lack of conviction in the reality of the symptom) or transient psychotic symptoms or a combination of genetic risk and functional deterioration. Schizophrenia Research xxx (2013) xxx-xxx Identifying CHR subjects in time is crucial for preventing or delaying the development of psychosis. Both pharmacological and psychological treatments (Miller et al., 2003b; Morrison et al., 2004; Ruhrmann et al., 2005; Morrison et al., 2007; Phillips et al., 2007) have demonstrated promise in improving symptoms in CHR subjects in recent years. A meta-analysis suggests that rates of transition to psychosis can be reduced significantly in CHR youth with specialized interventions (Preti and Cella, 2010) . However, the criteria for formal diagnosis of prodomal psychosis are still unavailable for clinicians (Raballo and Laroi, 2011) . Identification of individuals in the prodromal stage of psychosis remains largely reliant on research communities, criteria, and assessment methods worldwide. The predictive validity of the current criteria in different cultures and contexts needs to be better characterized before standardized criteria and treatment guidelines for this population can be developed and disseminated. Clinical characteristics and patterns of help-seeking may vary by cultural context and clinical setting. Given the limited social support and the pressure of social discrimination, psychological counseling may be an important channel for CHR subjects in China to talk about the distress caused by their symptoms. Thus, this setting may be particularly relevant for evaluating CHR criteria in China.
No doubt, much of the extant focus has been on establishing the percentage of CHR individuals participating in specialized research programs who end up developing psychosis over the course of follow-up. Yet, there is a lack of epidemiologic data regarding the prevalence and clinical features of CHR syndromes in people seeking help in general outpatient mental health clinics. Most putatively prodromal samples have been referred to researchers by clinicians. The question remains as to the number of CHR subjects in the broader clinic population from which these were selected. Furthermore, what was the clinical status of these individuals at initial contact with clinical services? These findings will be helpful to policy makers in planning early detection and intervention strategies. An epidemiological study on prodromal psychosis based on a clinical population is taken as the first step for both research and implementation of the new criteria of a high risk for psychosis syndrome. It will also highlight to Chinese clinicians the importance of the psychosis prodrome, a concept that may currently be relatively unfamiliar to psychiatrists in many regions of China.
The goal of the present study is to examine the presence of possibly prodromal symptoms of psychosis in a representative sample of individuals seeking psychological help for a broad range of psychopathology. The primary aim is to report the frequency of CHR syndromes in patients arriving for their first visit to a busy Chinese outpatient clinic. The second aim is to profile the clinical features of prodromal psychosis in Chinese clinical practice. We explore the relationship between positive symptoms and other non-specific symptoms. Finally, we report on the validity of the identified syndrome by comparing rates of transition to psychosis and presence of Axis I disorders to those of comparable samples worldwide. Findings are expected to inform the potential of implementing diagnostic criteria and assessment of prodromal psychosis in both clinical and research communities, and broader early intervention strategies for CHR subjects.
Method

Participants
The Research Ethics Committee at the Shanghai Mental Health Centre (SMHC) approved the study in 2011. The study sample comprised of patients attending their initial outpatient assessment in the SMHC, the largest mental health clinic in Shanghai, China. Inclusion criteria were: (i) age of 15-45 years old; (ii) individuals younger than 18 years old had to be accompanied by either a parent or legal guardian; (iii) capacity to provide informed consent or assent if under 18; and (iv) must have completed at least six years of primary education. Exclusion criteria were: (i) severe somatic diseases, for example, pneumonia, cancer or heart failure, (ii) mental retardation, or (iii) dementia.
Subjects approached were a consecutive series of those seeking an initial appointment at the psychological counseling service center according to the hospital register form.
Setting
The Shanghai Psychotherapy and Psychological Counseling Center (SPCC) at SMHC is the largest outpatient mental health clinic offering medication management and psychotherapy in China. The outpatients are from different parts of the country. The SPCC serves over 300 outpatients of all ages per day. There are approximately 1000 professional staff who provide care for the patients at the center. Among them, 258 are psychiatrists and psychologists and 541 are psychiatric nurses, along with other support staff. The SPCC provides comprehensive clinical services, including psychological assessment and counseling as well as medical management. Patients come seeking help for issues ranging from general psychological problems (e.g., interpersonal adaptation, marriage and learning difficulties) to more severe psychological disorders and mental illnesses (e.g., schizophrenia and bipolar disorder).
Measures
Screening
The Prodromal Questionnaire-Brief version (PQ-B, Loewy et al., 2011 ) is a 21-item self-report measure derived from the 92-item Prodromal Questionnaire (Loewy et al., 2005) . The PQ-B is designed to screen for possible prodromal symptoms. Respondents indicate the presence or absence of each symptom item with a "Yes/No". The total score is the number of items marked "Yes". For each symptom endorsed, the respondent indicates whether the symptom causes distress on a 5-point Likert scale (strongly disagree, disagree, neutral, agree, strongly agree). Loewy et al. (2011) found the PQ-B to be an effective, efficient self-report screening instrument for putatively prodromal syndromes in help-seeking populations with high sensitivity (89%) and medium specificity (58%) (a total score of 3 or more endorsed in PQ-B items, with the specificity of 68% and sensitivity of 88% while the distress score of 6 or more endorsed). The English version of the PQ-B was translated by the first and second authors (Zhang and Li) , under the supervision of the corresponding authors (Wang and Xiao).
Genetic risk information was assessed with one question about family history of mental disorders and questions probing DSM-IV schizotypal personality disorder (SPD). Subjects listed family members with mental disorders in response to an item querying a history of mental disorders in family members. Nine items were selected from the SPD subscale in PDQ-4+ (personality diagnostic questionnaire 4th edition plus) (Yang et al., 2002) . Subjects were asked to think about their behavioral patterns in the last 2 years and check the "Yes/No" checkbox.
CHR and psychosis assessment
The Structured Interview for Prodromal Syndromes (SIPS) and Scale of Prodromal Syndromes (SOPS, thus SIPS/SOPS, Miller et al., 2003a) were used to determine whether subjects met the criteria for a putatively prodromal syndrome (CHR status) or the Presence of a Psychotic Syndrome (POPS). The SIPS consists of 19 items assessing four symptom domains: positive symptoms (scales P1-P5, unusual thought content, suspiciousness, grandiosity, perceptual abnormalities, and disorganized communication), negative symptoms (scales N1-N6), disorganized symptoms (scales D1-D4), and general symptoms (scales G1-G4). The Criteria of Prodrome Syndromes (COPS) outline three syndromes: Brief Intermittent Psychotic Syndrome (BIPS), Attenuated Positive Symptom Syndrome (APSS), and Genetic Risk and Deterioration Syndrome (GRDS). Each item is rated on a 1-6 scale with 6 indicating "severe and psychotic" and 3-5 indicating a prodromal range symptom. POPS is determined by the presence of a 6 level P symptom that is either 1) dangerous or disorganizing or 2) occurring at least an hour a day on average four days a week for at least a month. BIPS is indicated by the recent onset of P symptoms rated at a 6 level and occurring at least a few minutes a day at least once a month but not at sufficient frequency or duration to meet the criteria for the POPS. APSS criteria are met by at least one P symptom rated 3-5, present at least once a week on average in the last month, and either new within the past year or rated at least one point higher (indicating worsening) than 1 year prior. GRDS is indicated by a functional deterioration (30% drop in Global Assessment of Functioning, GAF, score relative to 12 months prior) in the context of either schizotypal personality disorder or at least one first-degree relative with psychosis.
The English version SIPS/SOPS has demonstrated acceptable interrater reliability and predictive validity (Miller et al., 2002 (Miller et al., , 2003a . Agreement on P1-P5 scales differentiating prodromal from nonprodromal or psychotic patients after training workshops provided by Dr. Miller and other Yale University trainers has been satisfactory (kappa = 0.81, 95% CI = 0.55-0.93) (Miller et al., 2002) . The first and second authors were both certified on the SIPS at Yale Universitysponsored SIPS/SOPS trainings.
With written permission from the Yale authors, the SIPS/SOPS (Version 5) was translated into Chinese by our team and according to the strict international translation standard (Zheng et al., 2012) . First, the SIPS was translated into Chinese. The translators were bilingual and bicultural and were familiar with the instrument. Second, the translation was reviewed by a panel of individuals fluent in both English and Chinese and knowledgeable about both cultures. The panel reviewed and compared each translated item with the original English version. Third, the translation was revised reflecting the best judgment of the panel. Fourth, the second revision was then translated back into English by a native Chinese speaker who was fluent in English, but unfamiliar with the purpose of the study. Fifth, the back translation was compared to the original version. In particular, the second author (Li) facilitated appropriate attention to linguistic nuance and culturally-specific aspects of symptom presentation in the Chinese version of the SIPS. Preliminary SIPS data collected at SMHC (Zheng et al., 2012) show good inter-rater reliability (r = 0.96, p b 0.01 on the SOPS score). Expressed as the kappa value, the agreement rate between the four psychiatrists was 0.81-0.95. The inter-rater reliability (ICC) for the SIPS/SOPS positive symptoms ranged from ICC 0.86 (P5) to 0.98 (P4) within four raters. The Cronbach's α for all SOPS items was 0.71, and the total SOPS score correlated significantly with the Chinese PANSS total score (r = 0.63, p b 0.01).
Clinical diagnoses
The clinical diagnostic information of participants reported in this paper was from their outpatient medical records. All of the participants had received a clinical diagnosis of mental disorder from our psychiatrists using the criteria established in the third edition of the Chinese Classification and Diagnostic Criteria of Mental Disorders (CCMD-3; Chinese Society of Psychiatry, 2001 ). This is a clinical guide used in China for routine practice. Diagnoses defined in CCMD-3 are intentionally identical or similar in structure and categorization to international classifications (DSM-IV or ICD-10). The CCMD-3 consists of 10 main diagnostic categories such as schizophrenia and other psychotic disorders, affective disorders, neurosis (phobia, anxiety disorder, obsession, and somatoform disorders), and stress-related disorders (acute stress disorders, post-traumatic stress disorders, adjustment disorders).
Procedures
Similar to recruitment conducted at SMHC by this research team in 2006 (Zhang et al., 2012a,b) , all new patients seeking treatment at the SPCC between March and September 2011 were invited to participate in the study by a psychiatric triage nurse. After obtaining informed consent, the nurse gave participants the PQ-B. Participants meeting the following criteria were referred for a same-day SIPS/SOPS interview: (i) a total score of 3 or higher on the PQ-B; (ii) a PQ-B distress score of 6 or higher, and/or (iii) one or more first-degree relatives with affective or non-affective psychosis. To assess the false negative rate of PQ-B, we also randomly selected 20% of patients who did not meet these criteria to receive the SIPS/SOPS interview. SIPS interviews were conducted by four experienced psychiatrists who have received SIPS interview training (with a minimum of three years of psychiatric practice experience). Supervision of SIPS/SOPS interviews was conducted on a weekly or fortnightly basis by two senior psychiatrists.
Statistical analyses
Data were summarized using standard descriptive statistics in SPSS version 16.0 (SPSS, Inc., Chicago, IL, USA) statistical software. Independent-sample t-tests were used to test between group comparisons, as applicable. Significance was determined by p b 0.05 (two-tailed). For further graphical representation of the age distributions in the total sample, male/female groups and APSS/GRDS groups, bar diagrams showing the number of prodromal subjects by single year of age were prepared. A box-plot-diagram (Min, 25% Quartile, Median, 75% Quartile, Max) was created by SPSS software showing the difference in PQ-B total and distress scores among four groups divided as APSS, GDRS, POPS and control groups. Statistically significant differences among those CHR syndrome and psychosis groups were evaluated by one-way analysis of variance (ANOVA) followed by post-hoc Fisher's LSD multiple comparison tests. The correlation between positive symptoms and other subscales was calculated by nonparametric Spearman's rank-correlation analysis.
Results
Overall sample characteristics
Of the 2705 patients seeking treatment within the study period, 2101 subjects met the study entry inclusion criteria and consented to be screened. This sample consisted of 935 males (44.5%) and 1166 females (55.5%) with an average age of 27.1 years (SD = 7.4). Of these, 1681 subjects were screened as positive with the PQ-B, 1384 (82.3%) of whom completed the SIPS/SOPS interviews. Of the 420 subjects screened as negative, 77 (18.3%) completed the SIPS/SOPS interviews. A total of 89 subjects (4.2% of the initial 2101) met the criteria for a CHR syndrome, 87 patients who were initially screened positive, and 2 of those screened negative. A total of 105 subjects (5.0% of the initial 2101 subjects) met the criteria for POPS. The investigated 1907 sample who did not meet the criteria of APSS, GRDS and POPS (control group) included 835 males and 1072 females, with an average age of 27.4 years (SD = 7.3) (see Fig. 1 for a flowchart of the study sample).
More than two-thirds of the CHR patients met the criteria for APSS, while nearly a quarter met the criteria for GRDS and only three met the criteria for BIPS (see Table 1 ). The GRDS sample was significantly older than the APSS group (t = − 4.008, p b 0.01). The majority of CHR subjects (58.4%) were considered as having or were diagnosed with mood or anxiety disorders according to their medical records. Only a small minority who met the criteria for APSS was diagnosed as having schizophrenia by their clinicians. The mean percentage drop in GAF score over the past year in prodromal subjects was 26.4%, with GRDS patients having significantly larger GAF drops than APSS patients, partly by syndrome definition (t = −7.108, p b 0.01; see Table 1 ).
Age at CHR identification
The relationship between CHR syndrome and age is shown in Fig. 2 . The frequency of putatively prodromal psychosis or CHR in this sample peaked in early adulthood (16-21 years old) and declined with subsequent age. Compared to males, females presented with CHR syndromes during a broader age range (20-35 years old), with a slightly older age of peak frequency. Unlike males or patients in the APSS group for whom the peak frequency of CHR syndromes was in young adulthood, patients who met the criteria of GRDS were identified at highest frequency over 30 years old.
PQ-B scores and subsequent CHR syndrome identification
Perhaps not surprisingly, individuals with APSS and POPS endorsed significantly more symptoms on the PQ-B than either the GRDS or control group and both APSS and POPS groups reported significantly higher distress scores than the control group (see Table 2 and Fig. 3 ). The PQ-B cutoff point of total score of 3 or higher and distress score of 6 or higher for diagnosis of CHR yielded a sensitivity of 97.8% and a specificity of 20.8%. This cutoff point yielded a sensitivity of 97.4% and a specificity of 21.8% for identifying subjects with CHR or POPS. Table 3 shows the frequency of positive symptoms endorsed in the SIPS/SOPS interviews. The most frequent positive symptoms reported by CHR subjects were unusual thought content and suspiciousness, followed by perceptual abnormalities (see Table 3 for details). Social anhedonia, avolition and occupational functioning in negative symptoms, trouble with focus and attention in disorganized symptoms, sleep disturbance, dysphoric mood and impaired tolerance to normal stress in general symptoms were the most frequently identified negative, disorganized, and general symptoms. Table 4 shows the Spearman's rank correlation coefficients between positive symptoms, percentage drop of GAF and other subscales for 65 subjects with APSS (APSS criteria are met by at least one P symptom). There was a statistically significant unadjusted positive correlation (p b 0.01) between P1 and N6, P4 and N4, P5 and N1-6, and D4, and between a drop in GAF and N6 and G4. The strongest correlation (r = 0.517) was observed between a drop in GAF and G4.
SIPS/SOPS symptoms in Chinese help-seeking outpatients
Correlation of symptoms and functioning
Transition to psychosis outcomes
Through October 2013, 53/89 (59.6%) CHR subjects completed a two year follow-up assessment, 11 (12.4%) subjects withdrew from the study and 25 (28.1%) could not be reached by phone or mail. At follow-up, 12 out of the 53 subjects were available for face-to-face interview and the remaining 41 were available for telephone contact. SMHC medical records were available as well. Information on the CHR subjects was updated and recorded in the research files every year. Among the 53 CHR cases, 14 (26.4%) converted to psychosis. Specifically, 4 were hospitalized in psychiatric units and diagnosed with schizophrenia, 8 were diagnosed with schizophrenia at the outpatient clinic in the last two years, and 2 met the POPS criteria on interview. Among the 39 subjects who did not convert to full-blown psychosis, 21 were diagnosed with an Axis I disorder and had received treatment during the followup period. Ten out of the 39 remitted and no longer met the CHR criteria, and 8 had not converted but reported some attenuated psychotic symptoms at follow-up and were taking anti-psychotic medicine irregularly.
Discussion
There is a growing body of research into the early detection of prodromal psychosis in clinical samples worldwide (Broome et al., 2005; Yung et al., 2006; Addington et al., 2007; Cannon et al., 2008; Yung et al., 2008; Ruhrmann et al., 2009; Green et al., 2011) . However, most putatively prodromal samples are clinician-referred (Simon et al., 2006; Addington et al., 2008; Simon and Umbricht, 2010) . As reported in previous studies, nearly one third of such referrals meet the putatively prodromal criteria (Fusar-Poli et al., 2013b) . Thus, training clinicians would appear to be a more efficient early detection strategy than a clinic-wide screening. However, referrals to a third party (such as a research team) rarely occur in Chinese clinical practice and some cultural factors need to be considered. Patients experience being "kicked around" to different parts of the hospital, especially in a first visit, if sent for research. Doctors may worry that other clinicians or researchers will have different opinions about the diagnosis or treatment. Even the "referral" concept itself could lead patients to lose confidence in their doctors in China (Li et al., 2009) .
Whereas the concept of an "at risk mental state" had initially been used by Lam et al. (2006) in Hong Kong, China, the term of prodromal psychosis had not been formally researched and implemented in mainland China. Lam et al. found that about 29% of symptomatic individuals would transition to frank psychosis within a 6 month period of time. Such a high transition rate warrants attention from Chinese clinicians. However, the concept of "clinical high risk" is still largely unfamiliar in mainland China. Lack of standardized tools may partially account for this pattern. To our knowledge, our research group is one of the first to investigate the distribution of the CHR subjects in an epidemiological way in a clinical setting in mainland China. Examination of the clinical diagnoses of CHR subjects through clinic-based screening offers an additional perspective on the degree to which Chinese clinicians are currently recognizing psychosis and psychosis risk. Only one-fifth of CHR subjects detected through the broad clinic screening were considered to be possibly psychotic (e.g. schizophrenia was suspected) by Chinese clinicians, and less than one third were considered related to psychosis (including both diagnoses of psychosis and suspected psychosis). Most CHR subjects were treated for mood or anxiety disorders, which is not surprising, given the high rates of comorbid anxiety and depressive disorders in CHR samples (Salokangas et al., 2012; Fusar-Poli et al., in press) . It is reasonable that non-psychotic symptoms are more often of concern to both patients and clinicians. However, clinicians without sufficient training in the subtle pre-psychotic symptoms, particularly those with a genetic risk and significant drop in functioning, may miss identifying young people at risk (Rietdijk et al., 2012) . Extensive effort and significant resources are needed to recruit samples by clinical referral Addington et al., 2008) . Screening for early symptoms of emerging psychosis in help-seeking populations may be more effective for research recruitment and early intervention in China. The two-stage detection strategy described above, although involving intensive effort, identified 89 patients meeting the CHR status within just seven months, a significant recruitment rate compared to longstanding early intervention programs worldwide (Phillips et al., 2002; Addington et al., 2007; Fusar-Poli et al., 2013b) . It thus holds promise, not only for facilitating early intervention in China, but also for more rapidly advancing worldwide research with this population.
The effects of age and sex have been postulated to play a role in the onset of psychosis. We found that the peak age range of new patients meeting the prodromal syndrome criteria was between 16 and Note. The number of cases in BIPS, GRDS & APSS and GRDS & BIPS was no more than 3, so the individual data from subjects were listed. All the diagnostic information was collected from outpatients' medical records which were created by their attending doctors according to the Chinese mental health diagnostic manual. Here, "suspected" indicates a nonconclusive diagnosis. Take "suspected psychosis" as an example, when a clinician gives the diagnosis of "suspected schizophrenia" or "state of suspiciousness," we classify them into the "suspected psychosis" group. Fig. 2 . Age distribution for the total sample, male, female, APSS, and GRDS groups.
21 years old, which is largely consistent with other studies (Miller et al., 2002; Yung et al., 2007a,b; Morrison et al., 2011; Fusar-Poli et al., 2013b) . The mean age of our sample at 25.9 years was consistent with some clinical trials in adult cohorts (Allen et al., 2012; Koutsouleris et al., 2012) but it was older than the sample (N = 370) of the North American Prodrome Longitudinal Study (NAPLS), where the mean age is 18.2 (SD = 4.7 years) . Two things may account for this age difference. Firstly, we included subjects between 15 and 45 years old, while the NAPLS recruited subjects 12 to 35 years old. Secondly, our study recruited subjects who were not referred by clinicians.
We found an early and steep increase in frequency of prodromal syndromes between the age of 16 to 21 in males, and a delayed and gradual increase by age in females. Research indicates that male patients with schizophrenia have an earlier age of onset than females (Hafner et al., 1993; Faraone et al., 1994) . This phenomenon highlights the potential importance of differential screening by age and gender (e.g., expanding screening to older females). In addition, APSS subjects were younger than GRDS, and made up the majority of the CHR sample (70%). BIPS subjects were rare. Previous findings (Woods et al., 2009; Kelleher et al., 2012) have also found APSS to be the most common of the three prodromal syndromes according to the COPS criteria, with very low rates of BIPS in most CHR samples. Further research is needed to determine the relative predictive value of syndromes identified through screening in Chinese and other clinic samples will require follow-up over time. Findings from such studies could further inform best strategies for clinician training.
The results of the PQ-B are timely given that Chinese researchers have proposed the screening method as a better option for recruitment. Our preliminary data showed that the PQ-B could be a very useful tool for discriminating subjects with potentially psychotic symptoms from other help-seeking clients. The sensitivity of the PQ-B was excellent in this study. In fact, this clinic screening strategy detected over three times the typical rates of CHR subjects obtained via more traditional clinician referral methods. However, specificity of the traditional PQ-B cut-off in this sample was low. Outpatients seeking help in the hospital, may be likely to report high rates of "false positive" symptoms (the false positive rate in this study was 79.2%) on this screening questionnaire. For example, the question in the PQ-B "Do you worry at times that something may be wrong with your mind?" was responded positively for 72.8% of subjects. And the question of "Have you felt that you are not in control of your own ideas or thoughts?" was responded positively by 62.8% of subjects. With a higher cut-off point on the PQ-B, a twostage screening process combining the PQ-B and SIPS may result in a highly efficient recruitment method. High rates of GRDS detection in this study support the additional inclusion of a brief screening for genetic risk and schizotypal personality disorder. As other researchers have previously proposed (Broome et al., 2005; Rietdijk et al., 2012) , self-report screening measures can be quite useful to identifying a substantial subset of the CHR population.
Our investigation showed that "Unusual thought content", "suspiciousness" and "perceptual abnormalities" were prevalent in CHR individuals with positive symptoms. However, very few cases with "grandiose ideas" were identified in this sample. We suppose that grandiosity may be difficult to detect or less frequent in a helpseeking population (Hsiao et al., 1999) , especially in a first time meeting. In traditional Chinese culture, being modest is particularly valued, making it particularly unacceptable to share "grandiose ideas" with people on initial meeting (Oyserman and Lee, 2008) .
Although prodromal symptoms rely primarily on the presence of positive symptoms, non-specific symptoms such as negative symptoms, disorganizing symptoms, and general symptoms are quite common in CHR subjects. Indeed, our results suggest that some common nonspecific symptoms may be secondary to prodromal psychosis. Particularly, most negative symptoms were positively related with P1, P4 and P5. Based on published reports (Blanchard et al., 2005; Piskulic et al., 2012) , those non-specific symptoms may be vulnerability factors for developing psychosis. However, as the term "non-specific" suggests, these symptoms may predict other mental disorders such as depression and anxiety disorder as well (Addington et al., 2011) as suggested by the relatively high rates of comorbid Axis I disorders among CHR subjects (Fusar-Poli et al., in press; Myles-Worsley et al., 2007) . More research is needed to determine if these non-specific symptoms reflect secondary effects of positive symptoms or core symptoms in the early stage of psychosis. The present findings may also help direct clinicians to ask a more questions about subtle psychotic symptoms (mainly P1, unusual thought content, P2, suspiciousness, and P4, perceptual abnormalities) during initial visits, even when the patients' complaints are about depressive or anxious symptoms. The assessment of role function (such as school or work performance) should be a focus for identifying CHR subjects, especially for adolescents and young adults ages 16-21 years old or individuals with familial risk. Although there are no established guidelines for CHR treatment, a special team (for either research or service purpose) to better stratify the intervention activities and strategies is urgently needed in Chinese psychiatric or psychological medicine departments.
Finally, although the recruitment of a large sample of CHR is ongoing and the longitudinal follow-up has not been fully completed, there are preliminary 2 year follow-up conversion rate data. Among the 53 CHR participants who were followed-up for two years, 14 (26.4%) converted to psychosis, relatively consistent with the rates summarized in Fusar-Poli et al. (2013a) . Of the non-converters, 53.8% were diagnosed with Axis I disorders, also consistent with reports from other centers.
A further limitation is that, due to resource limitations, only a small proportion of those being screened negative by PQ-B received the more definitive SIPS/SOPS interviews. In fact, 2 out of the 77 screened negative subjects turned out to meet the criteria for a CHR syndrome. So it is possible that there were yet other undetected CHR cases among the 343 screened negative cases. This could lead to a significant underestimation of the true prevalence rate of CHR in the study population.
A final limitation of this study is that subjects were outpatients of the largest psychological counseling clinic in Shanghai, which is one of the mostly highly developed cities in China, limiting the generality of our finding to rural settings in China. Despite these limitations, the fact that this two stage screening method led to detection of Chinese CHR patients, for whom the rates of transition to psychosis and of Axis I disorders were comparable to those reported in meta-analyses, supports its validity in a large, urban, mental health center in China. Table 3 Frequency profiles for CHR subjects on SIPS/SOPS subscales.
SOPS items
Positive ( Note. Comorbid prodromal syndromes were not considered in this table. IQR: interquartile range. The mode is the value that appears most often in a set of data. 1 : one case was scored 6 (met the criteria of current psychosis). The number of cases in BIPS was only 3, so the raw data from BIPS for negative symptoms, disorganized symptoms and general symptoms were listed. ⁎ Correlation is significant at the 0.05 level (2-tailed). ⁎⁎ Correlation is significant at the 0.01 level (2-tailed).
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